Obermatt
See Similar Stocks →

Convatec Group

LSE:CTEC · GB00BD3VFW73
Health Care Equipment & SuppliesLarge

360

65
EV / EBIT73
Price / Owner Earnings28
Owner Earnings Yield53
Dividend Yield75
Price/Sales44
EV / Gross Profit57
Price/Book25
Return on Capital75
Cash Return on Capital67
Return on Equity72
EBIT Margin76
Gross Profitability68
Cash Conversion66
Accruals56
Owner Earnings Margin65
Sales growth60
Profit Growth76
Long-Term EPS Growth78
Owner Earnings Growth38
Reinvestment42
Price momentum17
Debt load23
Refinancing43
Debt Payback29
Liquidity54
Analyst ratings75
Opinion Changes74
Price Target Upside86
Market mood85
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Convatec Group clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUK
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeLSE
Founded2016
Employees5,147
Websiteconvatecgroup.com
ISINGB00BD3VFW73
Last UpdateApr 2, 2026
Indices
FTSE 100 (United Kingdom)FTSE 350 (United Kingdom)FTSE All Shares (United Kingdom)
Themes
NeurologyDiabetesChronic DiseasesUrologyHealth DiagnosticsSurgeryOncology

Description

ConvaTec Group PLC (Convatec) operates in the healthcare sector, focusing on the development, manufacture, and marketing of medical technologies and solutions that improve the quality of life for patients with chronic and transient medical conditions…

Analysis

Quality compounder

Convatec Group PLC is a quality compounder: a well-run business trading at a price that reflects what it is worth.

The price is fair. You pay 23.1× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 8% yearly growth; analysts expect 14%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 12/20 on our value-creation score: creating some value.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
60
2023202420252026

All-time high

77

Oct 2025

All-time low

30

Jan 2024

Average rank

57

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
44
49
48
78
Price/Earnings
64
56
50
78
Price/Book
25
22
16
73
Dividend Yield
75
84
74
65
Value (overall)
51
68
53
87

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Convatec Group with its peers
Ypsomed
SWX:YPSN
29
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
DiaSorin
MIL:DIA
34
CountryItaly
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
EDAP TMS
NMQ:EDAP
11
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Coloplast
CPH:COLO B
39
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Medacta Group
SWX:MOVE
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →